Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon.
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Central fatigue in multiple sclerosis: a review of the literature.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Glatiramer acetate induced hepatotoxicity.
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
Biomarkers of disease activity in multiple sclerosis.
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Dimethyl fumarate protection against collagen II degradation.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice.
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise.
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling.
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Glatiramer acetate inhibits degradation of collagen II by suppressing the activity of interferon regulatory factor-1.
PML in a patient treated with dimethyl fumarate from a compounding pharmacy.

Pages